Molecular and biochemical markers in colorectal cancer.
McDermott
U
U
Department of Oncology, Cancer Research Centre, Queen's University Belfast, Belfast, Northern Ireland.
Longley
D B
DB
Johnston
P G
PG
D000951:Antigens, Neoplasm / Q000032:analysis / Q000378:metabolism; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000032:analysis / Q000378:metabolism*; D018395:CA-19-9 Antigen / Q000235:genetics; D002272:Carcinoembryonic Antigen / Q000032:analysis / Q000378:metabolism; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D016158:Genes, p53 / Q000235:genetics; D011905:Genes, ras / Q000235:genetics; D005819:Genetic Markers / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000592:standards / Q000639:trends; D006801:Humans; D008297:Male; D018895:Microsatellite Repeats; D012680:Sensitivity and Specificity
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D002272:Carcinoembryonic Antigen; D005819:Genetic Markers